Apolipoprotein(a) Antisense Oligonucleotides: A New Treatment Option for Lowering Elevated Lipoprotein(a)?

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|23|10|1562-1570

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.23, Iss.10, 2017-05, pp. : 1562-1570

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antisense Oligonucleotides for the Treatment of Dyslipidemia

By  

Current Pharmaceutical Design, Vol. 17, Iss. 9, 2011-03 ,pp. : 950-960

Bentham Science Publishers

Access to resources Recommend Favorite

Rhesus monkey (Macaca mulatta) lipoprotein(a) and apolipoprotein(a): high frequency of small size apolipoprotein(a) isoforms

By  

JOURNAL OF MEDICAL PRIMATOLOGY, Vol. 44, Iss. 3, 2015-06 ,pp. : 117-124

John Wiley & Sons Inc

Access to resources Recommend Favorite

Antisense oligonucleotides as drugs for HIV treatment

By Galderisi U   Cipollaro M   Cascino A  

Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 10, 2001-10 ,pp. : 1605-1611

Informa Healthcare

Access to resources Recommend Favorite

Oncogene-targeted antisense oligonucleotides for the treatment of Ewing sarcoma

By Maksimenko Andrei   Malvy Claude  

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 4, 2005-08 ,pp. : 825-830

Informa Healthcare

Access to resources Recommend Favorite

Lipoprotein(a) Management: Pharmacological and Apheretic Treatment

By  

Current Medicinal Chemistry, Vol. 24, Iss. 10, 2017-05 ,pp. : 957-968

Bentham Science Publishers

Access to resources Recommend Favorite